The Bloc, one of the largest independent health creative agencies, announced the promotion of Jennifer Matthews to CEO and president. Founding partners Susan Miller Viray and Rico Viray assume the respective positions of chairman of The Bloc and chairman of the global network The BlocPartners.
CMI/Compas, media buying and planning for the nation’s top healthcare companies and part of WPP, announced the promotion of James Woodland to Chief Strategy and Financial Officer.
One is going, one is staying – and getting a promotion.
The loss of patent protection on two drugs is forcing Gilead Sciences to terminate about 20 percent of the company’s sales team, according to reports.
CMI/Compas, media planning and buying for the nation’s top healthcare companies and part of WPP, announced the promotion of John Donovan to President of Compas.
FCB Health Network president and CEO Dana Maiman announced that Kathleen Nanda has been promoted to executive creative director of FCB Health New York.
Ogilvy Health – part of The Ogilvy Group – announced Dan Chichester re-joined the network following a five-year hiatus, returning in the newly created position of Chief Experience Officer (CXO).
CMI/Compas announced the promotion of Dr. Susan Dorfman to President, CMI. Dorfman was previously Chief Commercial Officer for CMI/Compas.
HCB Health – a leading independent U.S. healthcare advertising agency – announced HCB Partner Nancy Beesley’s appointment as president, expanding her responsibilities and influence on the agency’s strategic and executive decisions.
AstraZeneca will pay up to $6.9 billion to work with Daiichi Sankyo on a hotly tipped experimental treatment for breast cancer, in a direct challenge to the world’s largest cancer drug maker Roche.
